DSS, Inc.

Historical 13F Holders

Reported Value, Excluding Options

Total Shares Held, Excluding Options

Total Filers

Every filing for 26253C201 since 12/18/2024, newest first.

Filer	% of Class	Shares	Form	Filed
Heng Fai Ambrose Chan 13D/A Amendment 24	86.3%	26,311,715	13D/A Amendment 24	9/8/2026 Event 9/3/2026
Heng Fai Ambrose Chan	86.3%	26,311,715
Alset Inc.	80.0%	24,407,472
Global Biomedical Pte. Ltd.	3.1%	311,634
Alset International Limited	71.0%	21,244,809
Heng Fai Ambrose Chan 13D/A Amendment 23	86.8%	26,464,246	13D/A Amendment 23	7/9/2026 Event 6/3/2026
Heng Fai Ambrose Chan	86.8%	26,464,246
Alset Inc.	80.0%	24,407,472
Global Biomedical Pte. Ltd.	3.1%	311,634
Alset International Limited	71.0%	21,244,809
Heng Fai Ambrose Chan 13D/A Amendment 22	68.2%	6,599,380	13D/A Amendment 22	9/2/2025 Event 8/28/2025
Heng Fai Ambrose Chan	68.2%	6,599,380
Alset Inc.	47.0%	4,542,606
Global Biomedical Pte. Ltd.	3.4%	311,634
Alset International Limited	15.2%	1,379,943
Heng Fai Ambrose Chan 13D/A Amendment 21	69.6%	6,730,059	13D/A Amendment 21	8/22/2025 Event 8/20/2025
Heng Fai Ambrose Chan	69.6%	6,730,059
Alset Inc.	47.0%	4,542,606
Global Biomedical Pte. Ltd.	3.4%	311,634
Alset International Limited	15.2%	1,379,943
Heng Fai Ambrose Chan 13D/A Amendment 20	67.6%	6,148,664	13D/A Amendment 20	2/10/2025 Event 2/6/2025
Heng Fai Ambrose Chan	67.6%	6,148,664
Alset Inc.	43.6%	3,961,211
Global Biomedical Pte. Ltd.	3.4%	311,634
Alset International Limited	15.2%	1,379,943

Period	Filers	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q3	3	4.00	$2.00	$0
2026 Q2	17	427 k	$252 k	$0
2026 Q1	18	225 k	$187 k	$0
2025 Q4	17	159 k	$148 k	$0
2025 Q3	15	146 k	$197 k	$0
2025 Q2	19	164 k	$154 k	$0
2025 Q1	15	165 k	$143 k	$0
2024 Q4	15	122 k	$110 k	$0
2024 Q3	13	172 k	$219 k	$0
2024 Q2	16	183 k	$315 k	$0
2024 Q1	16	163 k	$295 k	$0